| Title |
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
|
|---|---|
| Published in |
Drug Design, Development and Therapy, November 2018
|
| DOI | 10.2147/dddt.s138765 |
| Pubmed ID | |
| Authors |
Stephanie Vairy, Julia Lopes Garcia, Pierre Teira, Henrique Bittencourt |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 217 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 46 | 21% |
| Student > Master | 31 | 14% |
| Researcher | 19 | 9% |
| Student > Ph. D. Student | 18 | 8% |
| Other | 16 | 7% |
| Other | 20 | 9% |
| Unknown | 67 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 45 | 21% |
| Medicine and Dentistry | 25 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 9% |
| Immunology and Microbiology | 13 | 6% |
| Agricultural and Biological Sciences | 9 | 4% |
| Other | 30 | 14% |
| Unknown | 76 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#1,627,578
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#68
of 2,296 outputs
Outputs of similar age
#34,448
of 366,770 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 52 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,770 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.